Establishment and Application of the Drug Use Evaluation Criteria on Recombinant Human Granulocyte-col-ony Stimulating Factor for Cancer Patients / 中国药房
China Pharmacy
;
(12): 4050-4052,4053, 2016.
Article
in Chinese
| WPRIM
| ID: wpr-605483
ABSTRACT
OBJECTIVE:
To provide reference for rational use of recombinant human granulocyte-colony stimulating factor (rhG-CSF) in cancer patients.METHODS:
Referring to the expert advice and guideline of clinical application of rhG-CSF at home and abroad,DUE criteria on rhG-CSF for cancer patients was established;questionnaire was designed,and the medical re-cords of rhG-CSF in a third grade class A hospital was evaluated.RESULTS:
The DUE criterion on rhG-CSF for cancer patients included 3 parts,such as drug indications,the course of medication and medication results,14 items in total. Through the imple-mentation of DUE,retrospective evaluation of 220 medical records showed that the application of rhG-CSF was up to the stan-dard in respects of drug indications,no contraindication,routine blood test and drug interaction monitoring at least twice every week,there still was irrational phenomenon.CONCLUSIONS:
The established DUE criterion on rhG-CSF for cancer patients is with the characteristics of definite content,target and paracticabilitg,which can provide reference for the work development of clinical pharmacists.
Full text:
Available
Index:
WPRIM (Western Pacific)
Type of study:
Practice guideline
/
Qualitative research
Language:
Chinese
Journal:
China Pharmacy
Year:
2016
Type:
Article
Similar
MEDLINE
...
LILACS
LIS